Our Advantages

Experience & Expertise

Our team and leaders have years of experience in global biopharma companies. Our PMs are trained scientists with PhD degree in the US and Europe.

Flexible Collaboration Model

We support flexible collaboration models that fit different projects to meet diversified customer needs. In projects with limited budget, upon request, we take on more roles throughout the project life cycle.

Quality Management

GenScript ProBio developed the distinguishing Phase-appropriate Compliance (PAC) quality system to meet worldwide stringent regulatory standards (including US-FDA/EU-EMA/China-NMPA), which will benefit our customers in a way of high quality, cost-effectiveness, efficiency and credibility.

Capabilities & Capacity

Current capacity: up to 20 GCT IND and 400 L biologics.

Total 16,800 L bioreactors by 2023.

News & Activities

News 2021-04-21

GenScript ProBio collaborates with Singapore's Experimental Drug Development CentreLearn More »

News 2021-02-21

SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody ProgramLearn More »

News 2021-02-07

GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs Learn More »

News 2020-12-07

Initium Therapeutics Strategically collaborates with GenScript ProBioLearn More »

All News »

About ProBio

Partnership

Subscribe to receive updates & promotions from GenScript ProBio!

* We'll never share your email address with any third parties.